MitchellDTerkMD

Radiation Oncology • Jacksonville, FL

Director, Florida Physician Specialists; Terk Oncology; Florida Center for Prostate Care

Join to view full profile

Dr. Terk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Terk's full profile

Already have an account?

Office
710 Lomax St
Suite 1
Jacksonville, FL 32204
Phone+1 904-483-2310

Fax+1 904-483-2313

Education & Training

Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 1994 - 1998
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1993 - 1994
Icahn School of Medicine at Mount SinaiClass of 1993

Certifications & Licensure

NY State Medical License 1995 - 2026
FL State Medical License 1997 - 2025
GA State Medical License 2001 - 2017
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

205 citations
IDENTIFICATION OF PATIENTS AT INCREASED RISK FOR PROLONGED URINARY RETENTION FOLLOWING RADIOACTIVE SEED IMPLANTATION OF THE PROSTATE
Mitchell D. Terk, Richard G. Stock, Nelson N. Stone
The Journal of Urology. 1998-10-01
10 citations
Prostate cancer: the influence of stigma on quality of life and relationship satisfaction for survivors and their partners.
Andrew W. Wood, Sejal M. Barden, Mitchell Terk, Jamie A. Cesaretti
Journal of Psychosocial Oncology. 2019-05-01
7 citations
Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer.
Carlos Vargas, Now Bahar Alam, Mitchell Terk, Joshua R. Niska, Jamie A. Cesaretti
Cancer Treatment and Research Communications. 2019-01-01

Press Mentions

Terk OncologyJune 27th, 2019